UPMC Enterprises at BIO 2026: Partnering to Form New Care Models

The BIO International Convention brings together more than 20,000 life sciences professionals from over 70 countries each year, and 2026 was no exception.  In partnership with Life Sciences Pennsylvania, Matthias Kleinz, executive vice president; Jamie Bauersmith; vice president, and Parker Cahn, manager, were on the ground in San Diego, CA, representing UPMC Enterprises at the Pennsylvania Pavilion and connecting with colleagues from the biotech and life sciences community.

Across conversations with biopharma and innovation leaders, our team noted growing momentum in precision medicine and women’s health, driven by the search for more targeted, customized, and data-driven approaches to therapeutics discovery and care. The conference also saw increased pharma interest in regional ecosystems, where Pennsylvania stood out as a leading hub, drawing attention for the complementary strengths in life sciences innovation across its main hubs in Pittsburgh and Philadelphia and the state more broadly.

And among the many insights shared at this year’s event, several other notable trends stood out to our leadership team:

AI Adoption and Platform Partnerships are at an Inflection Point

“From my conversations at BIO, I’m seeing our industry at a number of inflection points: AI is moving beyond experimentation into operational adoption, pharma’s demand for real-world evidence continues to accelerate, and we’re seeing a shift from point solutions to platform-driven partnerships. UPMC Enterprises is uniquely positioned at the center of these trends, with the ability to build, test, and scale solutions inside a leading health system, enabling us to partner in ways that drive meaningful, system-level transformation.”

— Matthias Kleinz, executive vice president, UPMC Enterprises

Advancing Women’s Health Through Data-Driven Innovation and Precision Medicine

“Growing momentum in women’s health, particularly around precision medicine approaches for complex conditions like endometriosis and pre-eclampsia, was a major topic of our discussions. There’s a clear shift toward more targeted, data-driven care models and integrated approaches, and bringing together clinical expertise, real-world data, and trial execution are key to making that possible. That’s an area where UPMC Enterprises is especially well positioned to support partners and help drive meaningful innovation.”

— Jamie Bauersmith, vice president, UPMC Enterprises

Pennsylvania Showcases the Strength of Partnership-Driven Innovation in Life Sciences

“One of the biggest highlights this year was the strength and visibility of regional ecosystems, with pharma increasingly looking to partner within established, innovation-driven hubs. Pennsylvania stood out, with strong engagement across the Pavilion and clear momentum across the state.”

— Parker Cahn, manager, UPMC Enterprises

Partner With Us

Interested in learning more? We invite you to explore partnership opportunities and contact us for additional information.

Excited to bring BIO 2027 back to our home state — see you next year in Philadelphia!